News

The new laboratory is expected to deliver site support services to clinical investigators throughout China and offers overall benefits including shorter shipping distances between clinical sites and existing

As per the agreement, OctoPlus is expected to develop, making use of its PolyActive technology, in-vivo feasibility, a controlled release formulation of an undisclosed compound. Novartis is expected

Claros has been preparing its urology product for the European launch and continuing the process to attain regulatory clearance in other markets, including the US. The approval follows

Ganeden Biotech and Glanbia Nutritionals are expected to provide a stick pack containing an immune health micronutrient premix from Glanbia Nutritionals and GanedenBC30. GanedenBC30 is a probiotic that

Venlafaxine is an arylalkanolamine serotonin-norepinephrine reuptake inhibitor (SNRI). It has a similar chemical structure to the opioid derivative tramadol, and has the tertiary amine functional group necessary for

The USPTO recognised the template creation features that primary care and specialty practices can build upon and streamline to meet specific provider and practice needs. Greenway said that

Anastrozole is the generic version of Arimidex, a product of AstraZeneca. Anastrozole is an aromatase inhibitor, which interrupts a critical step in the body’s synthesis of estrogen. Some

Minister for Innovation, Industry, Science and Research of Australia has awarded $420,000 fund to Starpharma and MIPS as part of the ARC’s Linkage Projects scheme aimed at encouraging

The program covers glucagon analogs that may provide greater convenience and ease-of-use than the current recombinant glucagon for the treatment of severe hypoglycemia. The program includes MAR531, a